Enuresis nocturna: Forscherteam identifiziert Risikogene

2021 ◽  
Vol 16 (02) ◽  
pp. 99-100
Keyword(s):  
1965 ◽  
Vol 92 (4) ◽  
pp. 324-329 ◽  
Author(s):  
R. Lempp
Keyword(s):  

2004 ◽  
Vol 36 (4) ◽  
pp. 479-480 ◽  
Author(s):  
Ismet Yavascaoglu ◽  
Hakan Vuruskan ◽  
Yakup Kordan ◽  
Zulkuf Caliskan ◽  
Bulent Oktay

2012 ◽  
Vol 14 ◽  
pp. 37-43 ◽  
Author(s):  
M. I. Úbeda Sansano ◽  
R. Martínez García
Keyword(s):  

2005 ◽  
Vol 5 (2) ◽  
pp. 38-42 ◽  
Author(s):  
Elvedina Kapić ◽  
Fahir Bečić ◽  
Maida Todić

In this paper we have reviewed the possition of desmopressin in the treatment of diabetes insipidus. Desmopressin is a synthetic analog of vasopressin, with more pronounced antidiuretic effect. It is treatment of choice in substitution therapy of diabetes insipidus. Its application before sleeping time can reduce nocturnal enuresis, so it has a place in the treatment of enuresis nocturna. Antidiuretic effect of desmopressin is the result of agonistic effect on V2 receptors in the renal tubules. The efficacy and safety of desmopressin in mentioned indications was confirmed in clinical studies.


Sign in / Sign up

Export Citation Format

Share Document